0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Patricia Gaule, PhD; James W. Smithy, BS; Maria Toki, MD; et al.
JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.3015
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Mizuki Nishino, MD, MPH; Anita Giobbie-Hurder, MS; Hiroto Hatabu, MD, PhD; et al.
JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.2453
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Jun Young Seong, MD; Sook Hyun Kong, MD; Yu Sung Choi, MD, PhD; et al.
JAMA Dermatol. 2016;152(8):947-948. doi:10.1001/jamadermatol.2016.1098.

JAMA Oncology | 
Brief Report | 
Daniel E. Spratt, MD; Tiffany Chan, MA; Levi Waldron, PhD; et al.
JAMA Oncol. 2016;2(8):1070-1074. doi:10.1001/jamaoncol.2016.1854.

JAMA Oncology | 
Editorial | 
P. Mickey Williams, PhD; Barbara A. Conley, MD
JAMA Oncol. 2016;2(8):1003-1005. doi:10.1001/jamaoncol.2016.0240.

JAMA Oncology | 
Original Investigation | 
Adrian G. Sacher, MD; Cloud Paweletz, PhD; Suzanne E. Dahlberg, PhD; et al.
JAMA Oncol. 2016;2(8):1014-1022. doi:10.1001/jamaoncol.2016.0173.
Includes: Supplemental Content

JAMA Oncology | 
JAMA Oncology Clinical Evidence Synopsis |  ONLINE FIRST
Fábio Nasser Santos, MD; Marcelo Rocha Souza Cruz, MD; Rachel Riera, MD, MSC, PhD
JAMA Oncol. Published online July 28, 2016. doi:10.1001/jamaoncol.2016.2050

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;316(3):260. doi:10.1001/jama.2016.8833.

JAMA Ophthalmology | 
JAMA Ophthalmology Clinical Challenge | 
Paras Vakharia, PharmD; Yoshihiro Yonekawa, MD; Sandeep Randhawa, MD
JAMA Ophthalmol. 2016;134(7):835-836. doi:10.1001/jamaophthalmol.2015.5359.

JAMA Oncology | 
Review | 
Zofia Piotrowska, MD; Lecia V. Sequist, MD, MPH
JAMA Oncol. 2016;2(7):948-954. doi:10.1001/jamaoncol.2016.0333.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1
Patricia Gaule, PhD; James W. Smithy, BS; Maria Toki, MD; et al.
JAMA Oncology
Original Investigation  | 
Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino, MD, MPH; Anita Giobbie-Hurder, MS; Hiroto Hatabu, MD, PhD; et al.
JAMA Dermatology
Observation  | 
Necrolytic Migratory Erythema–like Skin Lesion During Gefitinib Treatment A Rare Cutaneous Adverse Reaction
Jun Young Seong, MD; Sook Hyun Kong, MD; Yu Sung Choi, MD, PhD; et al.
JAMA Oncology
Editorial  | 
Clinical Application of Liquid Biopsies
P. Mickey Williams, PhD; Barbara A. Conley, MD